Stay updated on PH94B Nasal Spray in Public Speaking Anxiety Clinical Trial
Sign up to get notified when there's something new on the PH94B Nasal Spray in Public Speaking Anxiety Clinical Trial page.

Latest updates to the PH94B Nasal Spray in Public Speaking Anxiety Clinical Trial page
- CheckyesterdayChange DetectedThe ClinicalTrials.gov page now displays the completed PH94B public-speaking anxiety study record, including its design, eligibility criteria, locations, results measures, and study documents.SummaryDifference52%

- Check8 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0 on the page displaying a 403 Forbidden error.SummaryDifference0.2%

- Check15 days agoChange DetectedA banner announces NIH website updates and says the agency is transitioning from the term “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check22 days agoChange DetectedThe footer’s site revision label changed from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check28 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check50 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record content, effectively blocking access to the study details. The surrounding site chrome remains visible, but the substantive information about the study is no longer accessible.SummaryDifference17%

Stay in the know with updates to PH94B Nasal Spray in Public Speaking Anxiety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PH94B Nasal Spray in Public Speaking Anxiety Clinical Trial page.